Literature DB >> 9874326

Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome.

A D Schachter1, G S Arbus, R J Alexander, J W Balfe.   

Abstract

We have followed four patients with Bartter syndrome for a mean of 25.4 years (range 21.5-28.8 years) after diagnosis. All patients received non-steroidal anti-inflammatory drugs (NSAID). In all patients, various degrees of renal dysfunction were noted to be temporally associated with NSAID therapy. In two patients, renal dysfunction resolved after discontinuing NSAID therapy, while maintaining other chronic medications such as potassium-sparing diuretics. Renal dysfunction persisted after NSAID withdrawal in two patients. We report these cases as a warning that NSAID should be considered an important cause of either reversible or irreversible renal dysfunction in Bartter syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874326     DOI: 10.1007/s004670050545

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  5 in total

1.  A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5.

Authors:  Takayuki Okamoto; Toshihiro Tajima; Tomoya Hirayama; Satoshi Sasaki
Journal:  Eur J Pediatr       Date:  2011-09-20       Impact factor: 3.183

2.  Chronic renal failure in a boy with classic Bartter's syndrome due to a novel mutation in CLCNKB coding for the chloride channel.

Authors:  Chien-Ming Lin; Jeng-Daw Tsai; Yi-Fen Lo; Ming-Tso Yan; Sung-Sen Yang; Shih-Hua Lin
Journal:  Eur J Pediatr       Date:  2008-12-03       Impact factor: 3.183

3.  Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis.

Authors:  Se Eun Lee; Kyoung Hee Han; Yun Hye Jung; Hyun Kyung Lee; Hee Gyung Kang; Kyung Chul Moon; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Korean J Pediatr       Date:  2011-01-31

4.  Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis.

Authors:  Hajime Yamazaki; Kandai Nozu; Ichiei Narita; Michio Nagata; Yoshimi Nozu; Xue Jun Fu; Masafumi Matsuo; Kazumoto Iijima; Fumitake Gejyo
Journal:  Pediatr Nephrol       Date:  2008-10-02       Impact factor: 3.714

Review 5.  Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.

Authors:  Hannsjörg W Seyberth; Karl P Schlingmann
Journal:  Pediatr Nephrol       Date:  2011-04-19       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.